The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...